Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies
- PMID: 1748227
- DOI: 10.1016/0028-2243(91)90319-g
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies
Similar articles
-
Oncoscint for detection of disseminated colorectal and ovarian cancer.Med Lett Drugs Ther. 1993 Jun 11;35(898):52-3. Med Lett Drugs Ther. 1993. PMID: 8497207 No abstract available.
-
[Radioimmunodetection of cancer].Nihon Rinsho. 1986 Mar;44(3):729-42. Nihon Rinsho. 1986. PMID: 3525900 Review. Japanese. No abstract available.
-
Challenges in immunoscintigraphy of ovarian cancer.Gynecol Oncol. 1993 Mar;48(3):283-4. doi: 10.1006/gyno.1993.1050. Gynecol Oncol. 1993. PMID: 8462895 No abstract available.
-
Influence of MAb (F(Ab)2 OC 125 on the survival rate of ovarian carcinoma patients.Hybridoma. 1993 Oct;12(5):567-70. doi: 10.1089/hyb.1993.12.567. Hybridoma. 1993. PMID: 8300131 Clinical Trial. No abstract available.
-
Monoclonal antibodies in ovarian and prostate cancer.Semin Nucl Med. 1993 Apr;23(2):114-26. doi: 10.1016/s0001-2998(05)80092-3. Semin Nucl Med. 1993. PMID: 8511599 Review.
Cited by
-
Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.Br J Cancer. 1996 Oct;74(7):1023-9. doi: 10.1038/bjc.1996.484. Br J Cancer. 1996. PMID: 8855969 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical